Human Investing’s CVS Health CVS Stock Holding History

Human Investing’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-760	Closed	-$56K	–	321
2019 Q4	$56K	Hold	760	–	–	0.02%	199
2019 Q3	$48K	Buy	+760	New	+$45K	0.02%	209

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Human Investing's CVS Position: Q1 2020 in Review

Human Investing sold out of CVS Health (CVS) in Q1 2020, closing a stake of 760 shares — an estimated $56K sold.

Human Investing first reported a position in CVS in Q3 2019 and held it in 2 quarters. The position peaked at $56K in Q4 2019. 1,817 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

Human Investing reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
Human Investing sold 760 CVS Health shares in Q1 2020, an estimated $56K.
Human Investing first reported a position in CVS Health in Q3 2019 and held it in 2 quarters.
Human Investing's CVS Health position peaked at $56K in Q4 2019.
1,817 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Human Investing's 13F filing for Q1 2020, filed 22 Apr 2020.